The Traumatic Brain Injury is a Brain dysfunction caused by an outside force, usually a violent blow to the head. Traumatic Brain Injury Pipeline provides the latest projects and drug profiles with key companies.
Introduction:
Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=911449 .
The Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Key Company Profiles:
ALSP Inc, Amarantus Bioscience Holdings Inc, Apollo Endosurgery Inc, Athersys Inc, Beech Tree Labs Inc, Cognosci Inc, Eustralis Pharmaceuticals Ltd, Intellect Neurosciences Inc, International Stem Cell Corp, Ischemix Inc, Karyopharm Therapeutics Inc, Kyorin Pharmaceutical Co Ltd, Levolta Pharmaceuticals Inc, Lixte Biotechnology Holdings Inc, MandalMed Inc, Mapreg SAS, Neuralstem Inc, Neuren Pharmaceuticals Ltd, Neurofx Inc, NeuroNascent Inc, NeuroVive Pharmaceutical AB, New World Laboratories Inc, NuvOx Pharma LLC, Omeros Corp, Oxeia Biopharmaceuticals Inc, PharmatrophiX Inc, Phylogica Ltd, Prevacus Inc, QR Pharma Inc, RegeneRx Biopharmaceuticals Inc, Remedy Pharmaceuticals Inc, Sage Therapeutics Inc, SanBio Inc, STATegics Inc, Stemedica Cell Technologies Inc, SynZyme Technologies LLC, Tetra Discovery Partners LLC, Thera Neuropharma Inc, vasopharm GmbH and VG Life Sciences Inc.
Post-Traumatic Stress Disorder (PTSD) - Drug Profiles:
(levocetirizine dihydrochloride + montelukast sodium) - Drug Profile, 2-DG - Drug Profile, ALP-496 - Drug Profile, AMRS-001 - Drug Profile, AST-002 - Drug Profile, AST-004 - Drug Profile, AVL-8168 - Drug Profile, BQ-A - Drug Profile, Cell Therapy to Activate hNT-3 for Spinal Cord and Traumatic Brain Injury - Drug Profile, CEVA-101 - Drug Profile, CEVA-102 - Drug Profile, CHEC-9 - Drug Profile, CMX-2043 - Drug Profile, CNB-001 - Drug Profile, COG-1410 - Drug Profile, cyclosporine - Drug Profile, dexamethasone acetate + melatonin - Drug Profile, EPO-Variant - Drug Profile, EUC-001 - Drug Profile, felbamate - Drug Profile, glyburide - Drug Profile, HBI-002 - Drug Profile, HBI-137 - Drug Profile, HBN-1 - Drug Profile, HBN-2 - Drug Profile, HPI-201 - Drug Profile, HPI-363 - Drug Profile, ibudilast - Drug Profile, ICCN-100 - Drug Profile, ISC-hpNSC - Drug Profile, JM-4 - Drug Profile, KPT-350 - Drug Profile, LB-201 - Drug Profile, LB-205 - Drug Profile, LM-22A4 - Drug Profile, LM11A-31BHS - Drug Profile, Lpathomab - Drug Profile, MAP-4343 - Drug Profile, Monoclonal Antibody for Central Nervous System - Drug Profile, N-acetyl cysteine amide - Drug Profile, ND-478 - Drug Profile, Neu-2000 - Drug Profile.

Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=911449
Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System).
The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System)
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=911449 .
Table of Contents:
Traumatic Brain Injury - Overview
Traumatic Brain Injury - Therapeutics Development
Traumatic Brain Injury Pipeline Overview
Traumatic Brain Injury Pipeline by Companies
Traumatic Brain Injury - Therapeutics Assessment
Traumatic Brain Injury - Companies Involved in Therapeutics Development
Traumatic Brain Injury - Drug Profiles
Traumatic Brain Injury - Dormant Projects
Traumatic Brain Injury - Product Development Milestones and more…

List of Tables.
Number of Products under Development for Traumatic Brain Injury, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Traumatic Brain Injury - Pipeline by ALSP Inc, H1 2017
Traumatic Brain Injury - Pipeline by QR Pharma Inc, H1 2017
Traumatic Brain Injury - Pipeline by Ischemix Inc, H1 2017
Traumatic Brain Injury - Dormant Projects, H1 2017 and more…

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.